1. Home
  2. CSBR vs GNSS Comparison

CSBR vs GNSS Comparison

Compare CSBR & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • GNSS
  • Stock Information
  • Founded
  • CSBR 1985
  • GNSS 1992
  • Country
  • CSBR United States
  • GNSS United States
  • Employees
  • CSBR N/A
  • GNSS N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • GNSS Consumer Electronics/Appliances
  • Sector
  • CSBR Health Care
  • GNSS Consumer Staples
  • Exchange
  • CSBR Nasdaq
  • GNSS Nasdaq
  • Market Cap
  • CSBR 113.0M
  • GNSS 98.9M
  • IPO Year
  • CSBR 1986
  • GNSS N/A
  • Fundamental
  • Price
  • CSBR $6.21
  • GNSS $2.07
  • Analyst Decision
  • CSBR Strong Buy
  • GNSS Strong Buy
  • Analyst Count
  • CSBR 1
  • GNSS 3
  • Target Price
  • CSBR $12.00
  • GNSS $5.33
  • AVG Volume (30 Days)
  • CSBR 42.0K
  • GNSS 58.3K
  • Earning Date
  • CSBR 03-11-2025
  • GNSS 05-13-2025
  • Dividend Yield
  • CSBR N/A
  • GNSS N/A
  • EPS Growth
  • CSBR N/A
  • GNSS N/A
  • EPS
  • CSBR 0.46
  • GNSS N/A
  • Revenue
  • CSBR $58,591,000.00
  • GNSS $26,587,000.00
  • Revenue This Year
  • CSBR $15.11
  • GNSS $121.93
  • Revenue Next Year
  • CSBR $7.80
  • GNSS $68.26
  • P/E Ratio
  • CSBR $12.94
  • GNSS N/A
  • Revenue Growth
  • CSBR 19.03
  • GNSS N/A
  • 52 Week Low
  • CSBR $3.60
  • GNSS $1.65
  • 52 Week High
  • CSBR $11.99
  • GNSS $4.04
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 36.72
  • GNSS 44.92
  • Support Level
  • CSBR $5.65
  • GNSS $1.93
  • Resistance Level
  • CSBR $8.27
  • GNSS $2.28
  • Average True Range (ATR)
  • CSBR 0.57
  • GNSS 0.11
  • MACD
  • CSBR -0.08
  • GNSS 0.00
  • Stochastic Oscillator
  • CSBR 21.67
  • GNSS 36.84

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

Share on Social Networks: